Ozemback is not medical advice. Ozemback is a cultural magazine. Nothing published on this site — including but not limited to essays, reportage, interviews, personal narrative, newsletters, social media content, and emails — is medical advice, medical guidance, diagnosis, treatment recommendation, or substitute for the judgment of a licensed clinician.
Reading Ozemback does not establish a clinician–patient or professional relationship of any kind. The editors are not licensed to practice medicine, nutrition counseling, mental health counseling, or pharmacy in any jurisdiction.
Always consult a qualified, licensed healthcare professional before starting, stopping, changing, or making any decision about any medication, supplement, hormone, peptide, intervention, diet, exercise program, or course of treatment. In a medical emergency call 911 (US) or your local emergency number. For mental health crisis in the US: 988.
What Ozemback does not do
To make this as plain as possible, Ozemback does not, and will never:
- Recommend a medication, dose, schedule, titration, cycle, stack, or protocol to anyone.
- Tell readers whether to start, continue, change, or stop any medication.
- Predict physiological outcomes for any individual reader.
- Endorse, refer to, or earn commission from clinics, prescribers, telehealth platforms, compounding pharmacies, or any entity that provides or sells medical services.
- Endorse, refer to, or earn commission from sellers of peptides, hormones, or non-FDA-approved substances for human use.
- Promise weight loss, cosmetic, or health outcomes of any kind.
- Provide individualized advice through email, newsletter, social media, or any other channel.
What Ozemback does
- Publish cultural reportage, essays, criticism, interviews, and personal narrative on the era of medicated weight loss as a cultural and historical phenomenon.
- Report on regulatory, scientific, and journalistic developments in the field — as journalism, not as guidance.
- Send a monthly newsletter with cultural essays and reading recommendations.
- Reference published peer-reviewed research and primary regulatory documents in the context of cultural reporting, citing sources for verification.
References to medications and trademarks
This site references medications by their proprietary and generic names — including Ozempic®, Wegovy®, Mounjaro®, Zepbound®, semaglutide, tirzepatide, retatrutide, orforglipron, and others — solely for editorial and cultural reporting purposes. These references do not constitute endorsement, sponsorship, recommendation, or partnership of any kind. All trademarks are the property of their respective owners.
References to peptides and non-FDA-approved substances
This site may reference peptides and other substances that are not FDA-approved for human therapeutic use, including but not limited to BPC-157, TB-500, GHK-Cu, CJC-1295, ipamorelin, tesamorelin, epithalon, AOD-9604, MOTS-c, and others. Such references are solely for cultural and journalistic context. Ozemback does not recommend, endorse, or instruct readers to acquire, possess, or use any such substance. Regulatory status varies by jurisdiction and changes over time. Consult appropriate professionals and applicable law in your jurisdiction before any decision.
No affiliation, no sponsorship, no medical conflicts of interest
Ozemback is an independent editorial project. As of the date of this notice, Ozemback receives no funding, sponsorship, advertising revenue, affiliate commission, or other financial benefit from: any pharmaceutical company; any clinic, telehealth platform, prescriber, or healthcare provider; any compounding pharmacy or laboratory; any peptide or hormone vendor; any supplement, nutraceutical, or weight-loss product company.
If Ozemback accepts sponsorship in the future — for example for the monthly newsletter or for individual editorial projects — it will be from cultural brands (books, kitchenware, beauty, mindfulness applications, food and meal services) and will be disclosed in plain language on the sponsored content. Medical sponsorship of any kind is permanently excluded.
Editorial standards
Ozemback strives for accuracy and honest sourcing. Where the magazine cites scientific or regulatory claims, the source and year are cited. Where the evidence is contested or thin, the magazine says so. Where the magazine reports a cultural phenomenon, it labels it as such. Where the magazine publishes opinion or personal essay, it labels it as such.
If you believe a published piece contains a factual error, write to info@ozemback.com. The magazine corrects in place and notes the correction.
Use of the site
By accessing or using ozemback.com, you agree to use the site for personal, non-commercial cultural reading purposes. You agree not to rely on any content on the site for medical decisions. You agree to seek and follow the advice of a licensed clinician for any medical question.
No warranties
The content is provided "as is" without warranties of any kind, express or implied. The magazine makes no warranty as to the accuracy, completeness, currency, or fitness for any particular purpose of any content.
Limitation of liability
To the fullest extent permitted by applicable law, Ozemback, its editors, contributors, and operators shall not be liable for any direct, indirect, incidental, consequential, special, punitive, or exemplary damages arising out of or in connection with your access to or use of the site or its content, including without limitation any decision you make or refrain from making based on anything you read here.
Indemnification
You agree to indemnify and hold harmless Ozemback, its editors, contributors, and operators from and against any claim, liability, damage, loss, or expense (including reasonable legal fees) arising out of your use of the site, your reliance on any content, or your violation of these terms.
Privacy & email
When you subscribe to the monthly newsletter, your email address and optional first name are stored in a private Google Sheet operated by the editor and used solely to send you the monthly letter. Your information is not sold, shared, rented, or transferred to any third party. You may unsubscribe at any time by replying to any newsletter email with the word REMOVE, and your data will be removed within seven days.
Governing law
These terms are governed by the laws of the State of Florida, United States, without regard to conflict of law principles. Any dispute arising under these terms shall be resolved in the courts of Miami-Dade County, Florida.
Changes to these terms
Ozemback may update these terms from time to time. Material changes will be noted with a revised "Last updated" date at the top of this page.
Contact
For any question, correction, takedown request, or business matter: info@ozemback.com. A human reads every email.